Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach.
Negredo E, Moltó J, Muñoz-Moreno JA, Pedrol E, Ribera E, Viciana P, Galindos MJ, Miralles C, Burger D, Rodriguez Fumaz C, Puig J, Gel S, Rodríguez E, Videla S, Ruiz L, Clotet B.
Negredo E, et al.
Antivir Ther. 2004 Jun;9(3):335-42.
Antivir Ther. 2004.
PMID: 15259896
Clinical Trial.